ReviewClinical reviews in allergy & immunology2010
Currents concepts on the immunopathology of amyloidosis.
Review in Clinical reviews in allergy & immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 60 citations in OpenAlex.
- Clinical characteristics and prognosis of immunoglobulin light chain amyloidosis patients.Frontiers in medicine · 2026Article
- Article
- Hepatomegaly and jaundice as the presenting symptoms of systemic light-chain amyloidosis: A case report.World journal of gastrointestinal oncology · 2024Article
- Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety.Current oncology (Toronto, Ont.) · 2023Article
- Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.Scientific reports · 2022Article
- Systemic Amyloidosis: a Contemporary Overview.Clinical reviews in allergy & immunology · 2020Review
- Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysis.Annals of hematology · 2020Article
- Real-Time 3D Imaging and Inhibition Analysis of Various Amyloid Aggregations Using Quantum Dots.International journal of molecular sciences · 2020Article
- Abdominal distension and diarrhea as the main symptoms of primary amyloidosis: A case report and literature review.Experimental and therapeutic medicine · 2016Article
- Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.Proceedings of the National Academy of Sciences of the United States of America · 2014Article
- Primary systemic Al amyloidosis presenting as temporal arteritis.Case reports in rheumatology · 2014Article
- Localized thymic amyloidosis presenting with myasthenia gravis: case report.Journal of Korean medical science · 2014Article
- Undiagnosed light chain systemic amyloidosis: does it matter to anesthesiologists? -a case report-.Korean journal of anesthesiology · 2013Article
- Small bowel amyloidosis.Current gastroenterology reports · 2013Review
- Primary systemic amyloidosis with extensive gastrointestinal involvement.Case reports in gastroenterology · 2013Article
- Light-chain amyloidosis: SCT, novel agents and beyond.Bone marrow transplantation · 2013Review
- The future of autoimmunity.Clinical reviews in allergy & immunology · 2012Article
- Mechanisms and pathophysiology of autoimmune disease.Clinical reviews in allergy & immunology · 2012Article
- Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis.Frontiers in neurology · 2012Article
- Light chain (AL) amyloidosis: update on diagnosis and management.Journal of hematology & oncology · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amyloidosis is defined as the extracellular accumulation at systemic or organ-specific level of insoluble low molecular weight protein fibrils manifesting a beta pleated sheet configuration and a characteristic staining pattern. Several different types of proteins may lead to this phenomenon, and amyloidosis is defined by the biochemical nature of the protein in the deposits and further classified according to whether the deposits are localized or systemic, acquired or inherited, and by the resulting clinical phenotype. Amyloidosis includes subtypes such as light chain, associated with serum amyloid A protein, heritable and familial forms, dialysis-related disease, and organ-specific conditions. The pathogenesis and clinical features of these clinical and pathological entities will be critically discussed in this review article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.